Updates on CAR T cell therapy in multiple myeloma
Abstract Multiple myeloma (MM) is a hematological cancer characterized by the abnormal proliferation of plasma cells. Initial treatments often include immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies (mAbs). Despite salient progress in diagnosis and treatment, m...
Saved in:
Main Authors: | Fatemeh Nasiri (Author), Yasaman Asaadi (Author), Farzaneh Mirzadeh (Author), Shahrokh Abdolahi (Author), Sedigheh Molaei (Author), Somayeh Piri Gavgani (Author), Fatemeh Rahbarizadeh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New cell sources for CAR-based immunotherapy
by: Marzieh Mazinani, et al.
Published: (2023) -
A comprehensive comparison between camelid nanobodies and single chain variable fragments
by: Yasaman Asaadi, et al.
Published: (2021) -
CAR-T cell potency: from structural elements to vector backbone components
by: Marzieh Mazinani, et al.
Published: (2022) -
Update on Multiple Myeloma
Published: (2019) -
Recent Updates on Multiple Myeloma
Published: (2023)